Literature DB >> 10897541

What does it cost the patient to see the doctor?

D P Kernick1, D M Reinhold, A Netten.   

Abstract

Against a background of increasing demands on limited resources, there will be an emphasis on undertaking studies that relate benefits of an intervention to the costs that are incurred in their production. Patient costs are an important, but often overlooked, part of an economic exercise and include transport costs, loss of employment, and loss of leisure time. This paper highlights the theoretical difficulties inherent in deriving patient costs and suggests a pragmatic framework to derive unit costs in these areas. We demonstrate that these costs are not inconsiderable when compared with the cost of a general practitioner consultation.

Entities:  

Mesh:

Year:  2000        PMID: 10897541      PMCID: PMC1313708     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  5 in total

1.  Costing interventions in primary care.

Authors:  D Kernick
Journal:  Fam Pract       Date:  2000-02       Impact factor: 2.267

2.  Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.

Authors:  J Posnett; S Jan
Journal:  Health Econ       Date:  1996 Jan-Feb       Impact factor: 3.046

Review 3.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  J E Siegel; M C Weinstein; L B Russell; M R Gold
Journal:  JAMA       Date:  1996 Oct 23-30       Impact factor: 56.272

4.  Some reflections on cost-effectiveness analysis.

Authors:  M Johannesson; D Meltzer
Journal:  Health Econ       Date:  1998-02       Impact factor: 3.046

Review 5.  The need for evidence-based medicine.

Authors:  D L Sackett; W M Rosenberg
Journal:  J R Soc Med       Date:  1995-11       Impact factor: 18.000

  5 in total
  5 in total

1.  Developing intermediate care provided by general practitioners with a special interest: the economic perspective.

Authors:  David P Kernick
Journal:  Br J Gen Pract       Date:  2003-07       Impact factor: 5.386

2.  Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis.

Authors:  R J McManus; J Mant; A Roalfe; R A Oakes; S Bryan; H M Pattison; F D R Hobbs
Journal:  BMJ       Date:  2005-08-22

Review 3.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  [Distribution of primary care expenditure according to sex and age group: a retrospective analysis].

Authors:  Alba Aguado; Daniel Rodríguez; Ferran Flor; Antoni Sicras; Amador Ruiz; Alexandra Prados-Torres
Journal:  Aten Primaria       Date:  2011-06-08       Impact factor: 1.137

5.  Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Change Observed.

Authors:  Loretto Lacey; Joel Bobula; Timothy Niecko; Christopher Leibman
Journal:  Neurol Ther       Date:  2016-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.